MONDAY, June 23, 2025 (HealthDay News) — For adults with obesity or overweight without diabetes, the novel cyclic adenosine monophosphate-biased glucagon like peptide 1 receptor agonist, ecnoglutide, yields a superior […]
The post ADA: Ecnoglutide Yields Superior, Sustained Reduction in Body Weight first appeared on Blackandmed .
